Venous thromboembolism complications in multiple myeloma
Zhaosheng Meng
Abstract
Zhaosheng Meng
Abstract
Multiple myeloma is a malignant tumor derived from plasmacytoid lymphocyte.An increased risk of VTE may occur in patients with multiple myeloma.The risk factors for VTE are high fixed state of blood,age,history of VTE,obesity,c omplications,centralvenous catheter,therapy with immune adjustment drug or multidrug chemotherapy.A study shows that incidence of VTE may decrease after prevention by receiving prophylaxis of venous thrombosis during treatment with drugs.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Multiple myeloma is a malignant tumor derived from plasmacytoid lymphocyte.An increased risk of VTE may occur in patients with multiple myeloma.The risk factors for VTE are high fixed state of blood,age,history of VTE,obesity,c omplications,centralvenous catheter,therapy with immune adjustment drug or multidrug chemotherapy.A study shows that incidence of VTE may decrease after prevention by receiving prophylaxis of venous thrombosis during treatment with drugs.
Key concepts: Medicine, Multiple myeloma, Incidence (geometry), Venous thromboembolism, Chemotherapy, Thrombosis, Internal medicine, Venous thrombosis